Cleavage stimulating factor 64 depletion mitigates cardiac fibrosis through alternative polyadenylation.
Cleavage stimulating factor 64 depletion mitigates cardiac fibrosis through alternative polyadenylation.
复制标题
裂解刺激因子64耗竭可通过替代聚腺苷酸化来减轻心脏纤维化。
DOI:
10.1016/j.bbrc.2022.01.093
复制
发表时间:
2022-03-15
影响因子:
3.1
通讯作者:
Thandavarayan, Rajarajan A.
中科院分区:
文献类型:
--
作者:
Neupane, Rahul;Youker, Keith;Yalamanchili, Hari Krishna;Cieslik, Katarzyna A.;Karmouty-quintana, Harry;Guha, Ashrith;Thandavarayan, Rajarajan A.
Alternative polyadenylation (APA) regulates gene expression by cleavage and addition of poly(A) sequence at different polyadenylation sites (PAS) in 3’UTR, thus, generating transcript isoforms with different lengths. Cleavage stimulating factor 64 (CstF64) is an APA regulator which plays a role in PAS selection and determines the length of 3’UTR. CstF64 favors the use of proximal PAS, resulting in 3’UTR shortening, which enhances the protein expression by increasing the stability of the target genes. The aim of this study is to investigate the role of CstF64 in cardiac fibrosis, a key event leading to heart failure (HF). We determined the expression of CstF64, key profibrotic genes, and their 3’UTR changes by calculating distal PAS (dPAS) usage in left ventricular (LV) tissues and cardiac fibroblasts from HF patients. CstF64 was upregulated in HF LV tissues and cardiac fibroblasts along with increased deposition of profibrotic genes such as COL1A and FN1 and significant shortening in their 3’UTR. In addition, HF cardiac fibroblasts showed increased transforming growth factor receptor β1 (TGFβR1) expression consistent with significant shortening in TGFβR1. Upon knockdown of CstF64 from HF fibroblasts, downregulation in profibrotic genes corresponding to lengthening in their 3’UTR was observed. Our finding suggests an important role of CstF64 in myofibroblast activation and promotion of cardiac fibrosis during HF through APA. Therefore, targeting CstF64 mediated RNA processing approach in human HF could provide a new therapeutic treatment strategy for limiting fibrotic remodeling. The model illustrates the effect of CstF64 upregulation on cardiac fibrosis.
登录
查看更多内容
影响因子:
14.9
作者:
Yang W;Hsu PL;Yang F;Song JE;Varani G
通讯作者:
Varani G
影响因子:
15.9
作者:
Weng, Tingting;Ko, Junsuk;Blackburn, Michael R.
通讯作者:
Blackburn, Michael R.
影响因子:
4
作者:
Murtha LA;Schuliga MJ;Mabotuwana NS;Hardy SA;Waters DW;Burgess JK;Knight DA;Boyle AJ
通讯作者:
Boyle AJ
影响因子:
16
作者:
Nam, Jin-Wu;Rissland, Olivia S.;Koppstein, David;Abreu-Goodger, Cei;Jan, Calvin H.;Agarwal, Vikram;Yildirim, Muhammed A.;Rodriguez, Antony;Bartel, David P.
通讯作者:
Bartel, David P.
影响因子:
20.1
作者:
Gibb AA;Lazaropoulos MP;Elrod JW
通讯作者:
Elrod JW